Core Viewpoint - Faruqi & Faruqi, LLP is investigating potential claims against Avantor, Inc. for alleged violations of federal securities laws, encouraging affected investors to discuss their legal options before the December 29, 2025 deadline for lead plaintiff applications in a federal securities class action [2][5]. Group 1: Allegations Against Avantor - The complaint alleges that Avantor and its executives made false and misleading statements regarding the company's competitive positioning and the impact of increased competition [5]. - Specific claims include that Avantor's competitive position was weaker than represented, and that the company was negatively affected by heightened competition [5][6]. Group 2: Financial Performance and Stock Impact - On April 25, 2025, Avantor reported disappointing Q1 2025 results, cutting its guidance and announcing the resignation of CEO Michael Stubblefield, leading to a stock price drop of over 16.5% [7]. - The company continued to report poor financial results, including a year-over-year decrease in net sales for Q2 2025, resulting in a further stock decline of over 15% [8][9]. - In Q3 2025, Avantor reported a net loss of $712 million and -5% organic revenue growth, attributed to competitive pressures, causing the stock to drop by more than 23% [10][11].

Q2 2025 Performance Highlights - Reported revenue reached $168 billion[10] - Adjusted Earnings per share was $024[10] - Adjusted EBITDA margin was 166%[10] - Free cash flow amounted to $125 million[10] Q2 2025 Financial Results - Reported revenue was $1683 million[16] - Adjusted gross profit was $554 million, representing 329% of revenues[16] - Adjusted EBITDA was $280 million, representing 166% of revenues[16] - Adjusted operating income was $252 million, representing 150% of revenues[16] Q2 2025 Performance by Segment - Laboratory Solutions reported revenue of $1122 million with an organic growth of -1% and adjusted operating income of $133 million, resulting in an adjusted operating margin of 119%[19] - Bioscience Production reported revenue of $561 million with an organic growth of 2% and adjusted operating income of $140 million, resulting in an adjusted operating margin of 249%[19] 2025 Full-Year Guidance - The company anticipates organic growth between -2% and 0%[22]

Q1 2025 Earnings Earnings Presentation April 25, 2025 Disclaimer Forward-looking statements This presentation contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and are subject to the safe harbor created thereby under the Private Securities Litigation Reform Act of 1995. All statements other than statements of historical fact included in this presentation are forward-looking statements. Forward-looking s ...